Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Bedard

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Journal of Urology|August 23, 2022
Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on SurveillanceAdam Bobrowski, Lynn Anson-Cartwright, Kopika Kuhathaas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 17, 2015
A classification system for clinical relevance of somatic variants identified in molecular profiling of cancerMahadeo A Sukhai, Kenneth J Craddock, Mariam Thomas, et al.
Plos One|September 22, 2010
Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS)Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas, et al.
European Urology Open Science|May 31, 2022
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell TumorsPeter J Gariscsak, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2017
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation optionsJeremy Lewin, Justin Ming Zheng Ma, Laura Mitchell, et al.
Urologic Oncology|April 4, 2026
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable diseaseAhmad Mousa, James Hayes, Ali Amiri, et al.
Breast Cancer Research : BCR|June 20, 2026
Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancerNickolas Stabellini, Sonia D de Oliveira, Takae Mizukami, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Journal of the National Cancer Institute|November 25, 2015
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsChristophe Le Tourneau, Maud Kamal, Apostolia-Maria Tsimberidou, et al.
The Lancet. Oncology|June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen typesSherene Loi, W Fraser Symmans, John M S Bartlett, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Journal of Urology|August 23, 2022
Role of Lactate Dehydrogenase in Identifying Relapse for Patients With Stage I Testicular Cancer on SurveillanceAdam Bobrowski, Lynn Anson-Cartwright, Kopika Kuhathaas, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 17, 2015
A classification system for clinical relevance of somatic variants identified in molecular profiling of cancerMahadeo A Sukhai, Kenneth J Craddock, Mariam Thomas, et al.
Plos One|September 22, 2010
Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS)Jérôme Toussaint, Virginie Durbecq, Sevilay Altintas, et al.
European Urology Open Science|May 31, 2022
Safety of Minimizing Intensity of Follow-up on Active Surveillance for Clinical Stage I Testicular Germ Cell TumorsPeter J Gariscsak, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 4, 2017
The positive effect of a dedicated adolescent and young adult fertility program on the rates of documentation of therapy-associated infertility risk and fertility preservation optionsJeremy Lewin, Justin Ming Zheng Ma, Laura Mitchell, et al.
Urologic Oncology|April 4, 2026
Postchemotherapy orchiectomy in metastatic testicular germ cell tumors: Pathologic findings and predictors of residual viable diseaseAhmad Mousa, James Hayes, Ali Amiri, et al.
Breast Cancer Research : BCR|June 20, 2026
Impact of somatic PIK3CA mutations on clinical outcomes in HER2-positive breast cancerNickolas Stabellini, Sonia D de Oliveira, Takae Mizukami, et al.
BJU International|July 5, 2024
Primary retroperitoneal lymph node dissection for metastatic non-seminomatous germ cell tumours: outcomes and adjuvant chemotherapyAhmad Mousa, Lynn Anson-Cartwright, Eshetu G Atenafu, et al.
Journal of the National Cancer Institute|November 25, 2015
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsChristophe Le Tourneau, Maud Kamal, Apostolia-Maria Tsimberidou, et al.
The Lancet. Oncology|June 21, 2011
Proposals for uniform collection of biospecimens from neoadjuvant breast cancer clinical trials: timing and specimen typesSherene Loi, W Fraser Symmans, John M S Bartlett, et al.
Pageof 3